{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:17:24Z","timestamp":1793193444359,"version":"4.5.0"},"reference-count":53,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T00:00:00Z","timestamp":1669420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Research Council (ERC)","award":["771083"],"award-info":[{"award-number":["771083"]}]},{"name":"European Research Council (ERC)","award":["110043"],"award-info":[{"award-number":["110043"]}]},{"name":"European Research Council (ERC)","award":["SFB-TRR57\/P06"],"award-info":[{"award-number":["SFB-TRR57\/P06"]}]},{"name":"European Research Council (ERC)","award":["LU 1360\/3-1"],"award-info":[{"award-number":["LU 1360\/3-1"]}]},{"name":"European Research Council (ERC)","award":["CRC1380\/A01"],"award-info":[{"award-number":["CRC1380\/A01"]}]},{"name":"European Research Council (ERC)","award":["CA 830\/3-1"],"award-info":[{"award-number":["CA 830\/3-1"]}]},{"name":"German Cancer Aid","award":["771083"],"award-info":[{"award-number":["771083"]}]},{"name":"German Cancer Aid","award":["110043"],"award-info":[{"award-number":["110043"]}]},{"name":"German Cancer Aid","award":["SFB-TRR57\/P06"],"award-info":[{"award-number":["SFB-TRR57\/P06"]}]},{"name":"German Cancer Aid","award":["LU 1360\/3-1"],"award-info":[{"award-number":["LU 1360\/3-1"]}]},{"name":"German Cancer Aid","award":["CRC1380\/A01"],"award-info":[{"award-number":["CRC1380\/A01"]}]},{"name":"German Cancer Aid","award":["CA 830\/3-1"],"award-info":[{"award-number":["CA 830\/3-1"]}]},{"name":"German-Research-Foundation","award":["771083"],"award-info":[{"award-number":["771083"]}]},{"name":"German-Research-Foundation","award":["110043"],"award-info":[{"award-number":["110043"]}]},{"name":"German-Research-Foundation","award":["SFB-TRR57\/P06"],"award-info":[{"award-number":["SFB-TRR57\/P06"]}]},{"name":"German-Research-Foundation","award":["LU 1360\/3-1"],"award-info":[{"award-number":["LU 1360\/3-1"]}]},{"name":"German-Research-Foundation","award":["CRC1380\/A01"],"award-info":[{"award-number":["CRC1380\/A01"]}]},{"name":"German-Research-Foundation","award":["CA 830\/3-1"],"award-info":[{"award-number":["CA 830\/3-1"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Cancer represents one of the leading causes of death worldwide. Besides genetic risk factors and non-communicable diseases, chronic infections including Epstein\u2013Barr virus (EBV) infection have been identified as promotors of cancer. In the present manuscript, we evaluated the association between infectious mononucleosis, the clinical manifestation of EBV infection, and cancer development in a real-word cohort of outpatients in Germany. Methods: We used the Disease Analyzer database (IQVIA) and matched a total of 12,095 patients with infectious mononucleosis to a cohort of individuals without infectious mononucleosis based on age, sex, index year, and annual patient consultation frequency between 2000 and 2018. Results: Patients diagnosed with infectious mononucleosis had a cancer incidence of 5.3 cases per 1000 person years versus 4.4 cases per 1000 person years for patients without infectious mononucleosis. In multivariable regression models, infectious mononucleosis showed a trend towards a higher incidence of cancer in general in the age group &gt; 50 years (incidence rate ratio (IRR): 1.32; 95% CI: 1.04\u20131.67) and among men (IRR: 1.36; 95% CI: 1.07\u20131.72). Infectious mononucleosis was significantly associated with an increased incidence of tumors of the hematopoietic and lymphoid tissues (IRR: 1.75; 95% CI: 1.22\u20132.50) and showed a strong trend towards an association with prostate cancer (IRR: 3.09; 95% CI: 1.23\u20137.76). Conclusion: Infectious mononucleosis is associated with an increased incidence of certain cancer types. The present data from a large real-world cohort support the evidence on a role of EBV in the development of different malignancies and could trigger research efforts to further elucidate its precise involvement in the carcinogenic process.<\/jats:p>","DOI":"10.3390\/cancers14235837","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T07:01:30Z","timestamp":1669618890000},"page":"5837","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Association between Infectious Mononucleosis and Cancer: A Cohort Study of 24,190 Outpatients in Germany"],"prefix":"10.3390","volume":"14","author":[{"given":"Christoph","family":"Roderburg","sequence":"first","affiliation":[{"name":"Department for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Duesseldorf, Medical Faculty of Heinrich Heine University Duesseldorf, 40225 Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0012-0304","authenticated-orcid":false,"given":"Sarah","family":"Krieg","sequence":"additional","affiliation":[{"name":"Department for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Duesseldorf, Medical Faculty of Heinrich Heine University Duesseldorf, 40225 Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2496-1079","authenticated-orcid":false,"given":"Andreas","family":"Krieg","sequence":"additional","affiliation":[{"name":"Department of Surgery (A), University Hospital Duesseldorf, Medical Faculty of Heinrich Heine University Duesseldorf, 40225 Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Luedde","sequence":"additional","affiliation":[{"name":"Department for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Duesseldorf, Medical Faculty of Heinrich Heine University Duesseldorf, 40225 Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2124-7227","authenticated-orcid":false,"given":"Karel","family":"Kostev","sequence":"additional","affiliation":[{"name":"Epidemiology, IQVIA, 60549 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2799-2287","authenticated-orcid":false,"given":"Sven H.","family":"Loosen","sequence":"additional","affiliation":[{"name":"Department for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Duesseldorf, Medical Faculty of Heinrich Heine University Duesseldorf, 40225 Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,26]]},"reference":[{"key":"ref_1","unstructured":"Ferlay, J.L.M., Ervik, M., Lam, F., Colombet, M., Mery, L., Pi\u00f1eros, M., Znaor, A., Soerjomataram, I., and Bray, F. (2020). Global Cancer Observatory: Cancer Tomorrow, International Agency for Research on Cancer. Available online: https:\/\/gco.iarc.fr\/tomorrow."},{"key":"ref_2","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2022, November 15). Epstein-Barr Virus and Kaposi\u2019s Sarcoma Herpesvirus\/Human Herpesvirus 8. Lyon (FR): International Agency for Research on Cancer; 1997. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 70), Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK385507\/."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: A worldwide incidence analysis","volume":"8","author":"Georges","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcv.2018.03.001","article-title":"Primary Epstein-Barr virus infection","volume":"102","author":"Dunmire","year":"2018","journal-title":"J. Clin. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e037505","DOI":"10.1136\/bmjopen-2020-037505","article-title":"Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990\u20132017","volume":"10","author":"Khan","year":"2020","journal-title":"BMJ Open"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.5414\/CP203320","article-title":"Basic characteristics and representativeness of the German Disease Analyzer database","volume":"56","author":"Rathmann","year":"2018","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e14690","DOI":"10.1111\/ijcp.14690","article-title":"Clinical characteristics and sick leave associated with infectious mononucleosis in a real-world setting in Germany","volume":"75","author":"Kap","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"937583","DOI":"10.3389\/fimmu.2022.937583","article-title":"Infectious mononucleosis is associated with an increased incidence of multiple sclerosis: Results from a cohort study of 32,116 outpatients in Germany","volume":"13","author":"Loosen","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jnci\/50.2.315","article-title":"Infectious mononucleosis and the empirical risk of cancer","volume":"50","author":"Miller","year":"1973","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/jnci\/92.18.1522","article-title":"Risk of Hodgkin\u2019s disease and other cancers after infectious mononucleosis","volume":"92","author":"Hjalgrim","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1054\/bjoc.1999.1049","article-title":"Risk factors for Hodgkin\u2019s disease by Epstein-Barr virus (EBV) status: Prior infection by EBV and other agents","volume":"82","author":"Alexander","year":"2000","journal-title":"Br. J. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/oxfordjournals.aje.a112352","article-title":"Cancer incidence following infectious mononucleosis","volume":"105","author":"Carter","year":"1977","journal-title":"Am. J. Epidemiol."},{"key":"ref_14","first-page":"1172","article-title":"A cohort study of cancer following infectious mononucleosis","volume":"34","author":"Connelly","year":"1974","journal-title":"Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.2.5913.253","article-title":"Hodgkin\u2019s disease in patients with previous infectious mononucleosis: 30 years\u2019 experience","volume":"2","author":"Rosdahl","year":"1974","journal-title":"Br. Med. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ijc.2910220104","article-title":"Infectious mononucleosis and Hodgkin\u2019s disease","volume":"22","author":"Davidson","year":"1978","journal-title":"Int. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ijc.2910230502","article-title":"Hodgkin\u2019s disease in patients with previous infectious mononucleosis","volume":"23","author":"Pedersen","year":"1979","journal-title":"Int. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJM198101153040302","article-title":"Childhood social environment and Hodgkin\u2019s disease","volume":"304","author":"Gutensohn","year":"1981","journal-title":"New Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0950-3536(96)80018-7","article-title":"The epidemiology of Hodgkin\u2019s disease","volume":"9","author":"Glaser","year":"1996","journal-title":"Baillieres Clin. Haematol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0140-6736(91)90943-J","article-title":"Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin\u2019s disease","volume":"337","author":"Pallesen","year":"1991","journal-title":"Lancet"},{"key":"ref_21","first-page":"86","article-title":"Epstein-Barr viral DNA in tissues of Hodgkin\u2019s disease","volume":"129","author":"Weiss","year":"1987","journal-title":"Am. J. Pathol."},{"key":"ref_22","unstructured":"Schottenfeld, D., and Fraumeni, J.J. (1996). Hodgkin\u2019s disease. Cancer Epidemiology and Prevention, Oxford University Press. [2nd ed.]."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"10399","DOI":"10.1038\/s41598-022-14511-4","article-title":"Detection and characterization of latency stage of EBV and histopathological analysis of prostatic adenocarcinoma tissues","volume":"12","author":"Ahmed","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"20160270","DOI":"10.1098\/rstb.2016.0270","article-title":"Epstein-Barr virus infection and nasopharyngeal carcinoma","volume":"372","author":"Tsao","year":"2017","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ctrv.2018.03.006","article-title":"Outlooks on Epstein-Barr virus associated gastric cancer","volume":"66","author":"Naseem","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Osorio, J.C., Blanco, R., Corval\u00e1n, A.H., Mu\u00f1oz, J.P., Calaf, G.M., and Aguayo, F. (2022). Epstein-Barr Virus Infection in Lung Cancer: Insights and Perspectives. Pathogens, 11.","DOI":"10.3390\/pathogens11020132"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Becnel, D., Abdelghani, R., Nanbo, A., Avilala, J., Kahn, J., Li, L., and Lin, Z. (2021). Pathogenic Role of Epstein-Barr Virus in Lung Cancers. Viruses, 13.","DOI":"10.3390\/v13050877"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.2169\/internalmedicine.49.3978","article-title":"Graves\u2019 disease associated with infectious mononucleosis due to primary Epstein-Barr virus infection: Report of 3 cases","volume":"49","author":"Akahori","year":"2010","journal-title":"Intern. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5603\/EP.2015.0020","article-title":"The role of Epstein-Barr virus infection in the development of autoimmune thyroid diseases","volume":"66","author":"Janegova","year":"2015","journal-title":"Endokrynol. Pol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/milmed\/129.6.533","article-title":"The Hepatitis of Infectious Mononucleosis: Experience with 235 cases","volume":"129","author":"Finkel","year":"1964","journal-title":"Mil. Med."},{"key":"ref_32","first-page":"1279","article-title":"Epstein-Barr virus infectious mononucleosis","volume":"70","author":"Ebell","year":"2004","journal-title":"Am. Fam. Physician"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejim.2010.07.016","article-title":"Epstein Barr virus hepatitis","volume":"22","author":"Kofteridis","year":"2011","journal-title":"Eur. J. Intern. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1086\/505400","article-title":"A cohort study among university students: Identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis","volume":"43","author":"Crawford","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00106-004-1210-1","article-title":"Infectious mononucleosis","volume":"53","author":"Walther","year":"2005","journal-title":"Hno"},{"key":"ref_36","unstructured":"Knipe, D.M., Howley, P.M., Griffin, D.E., Lamb, R.A., Martin, M.A., Roizman, B., and Straus, S.E. (2007). Epstein-Barr virus and its replication. Field\u2019s Virology, Lippincott Williams & Wilkins."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.virusres.2009.07.005","article-title":"The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: A need for reappraisal","volume":"143","author":"Chang","year":"2009","journal-title":"Virus Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.18632\/oncotarget.14380","article-title":"The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers","volume":"8","author":"Tsai","year":"2017","journal-title":"Oncotarget"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/jcp.2006.044586","article-title":"Epstein Barr virus-associated tumours: An update for the attention of the working pathologist","volume":"60","author":"Delecluse","year":"2007","journal-title":"J. Clin. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc.2016.92","article-title":"Epstein-Barr virus: More than 50 years old and still providing surprises","volume":"16","author":"Young","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3389\/fonc.2019.00713","article-title":"The Global Landscape of EBV-Associated Tumors","volume":"9","author":"Rickinson","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1128\/JVI.03614-14","article-title":"Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection","volume":"89","author":"Palser","year":"2015","journal-title":"J. Virol."},{"key":"ref_43","first-page":"119","article-title":"Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Types","volume":"390","author":"Feederle","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1158\/1055-9965.EPI-08-1175","article-title":"Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: A 20-year follow-up study on 9622 males without family history in Taiwan","volume":"18","author":"Hsu","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nrmicro2015","article-title":"The curious case of the tumour virus: 50 years of Burkitt\u2019s lymphoma","volume":"6","author":"Allday","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/346470a0","article-title":"Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region","volume":"346","author":"Lu","year":"1990","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2818.1978.tb00086.x","article-title":"Low cost internegatives from electron micrographs of metal shadowed objects","volume":"112","author":"Boye","year":"1978","journal-title":"J. Microsc."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"36614","DOI":"10.1074\/jbc.M706324200","article-title":"Isolating the Epstein-Barr virus gp350\/220 binding site on complement receptor type 2 (CR2\/CD21)","volume":"282","author":"Young","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1128\/JVI.00445-07","article-title":"Epstein-Barr virus entry","volume":"81","year":"2007","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Schneider, F., Neugebauer, J., Griese, J., Liefold, N., Kutz, H., Brise\u00f1o, C., and Kieser, A. (2008). The viral oncoprotein LMP1 exploits TRADD for signaling by masking its apoptotic activity. PLoS Biol., 6.","DOI":"10.1371\/journal.pbio.0060008"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1084\/jem.20072581","article-title":"An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival","volume":"205","author":"Choy","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ijc.28007","article-title":"Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma","volume":"133","author":"Lei","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_53","first-page":"149","article-title":"Epstein-Barr virus infection and human malignancies","volume":"82","author":"Niedobitek","year":"2001","journal-title":"Int. J. Exp. Pathol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/23\/5837\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:27:33Z","timestamp":1760146053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/23\/5837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,26]]},"references-count":53,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["cancers14235837"],"URL":"https:\/\/doi.org\/10.3390\/cancers14235837","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,26]]}}}